563 Results

People

  1. Zelenetz
    Zelenetz
  2. Moskowitz
    Moskowitz
  3. Yahalom
    Yahalom
  4. Noy
    Noy
  5. De Angelis
    De Angelis
  6. Perales
    Perales
  7. Abrey
    Abrey
  8. Palomba
    Palomba
  9. Younes
    Younes
  10. Matasar
    Matasar

Groups

  1. Department of Medicine (377)
  2. Hematologic Malignancies, Division of (338)
  3. Center for Hematologic Malignancies (292)
  4. Lymphoma (192)
  5. Survivorship Research (98)
  6. Tow Center for Developmental Oncology (TCDO) (72)
  7. Bone Marrow Transplant (65)
  8. GSK Faculty (60)
  9. Epidemiology and Biostatistics (58)
  10. Adult Leukemia (53)
  1. "rituximab"
Formats
  1. Journal Article (489)
  2. Review (36)
  3. Research Letter (13)
  4. Editorial (9)
  5. Correspondence (6)
  6. Meeting Abstract (4)
  7. Book Section (2)
  8. Conference Paper (2)
  9. Guidelines (2)
Groups
  1. Department of Medicine (377)
  2. Hematologic Malignancies, Division of (338)
  3. Center for Hematologic Malignancies (292)
  4. Lymphoma (192)
  5. Survivorship Research (98)
  6. Tow Center for Developmental Oncology (TCDO) (72)

More Groups

People
  1. Andrew Zelenetz (87)
  2. Craig Moskowitz (52)
  3. Joachim Yahalom (39)
  4. Ariela Noy (35)
  5. Lisa De Angelis (32)
  6. Paul Hamlin (32)

More People

Years
  1. 2025 (21)
  2. 2024 (36)
  3. 2023 (36)
  4. 2022 (28)
  5. 2021 (14)
  6. 2020 (25)

More Years

Publications
  1. Blood (43)
  2. Leukemia and Lymphoma (38)
  3. Journal of Clinical Oncology (32)
  4. Haematologica (21)
  5. British Journal of Haematology (20)
  6. Journal of the National Comprehensive Cancer Network (16)

More Publications

Publishers
  1. Elsevier Inc. (70)
  2. American Society of Hematology (61)
  3. Taylor & Francis Group (44)
  4. Springer (42)
  5. American Society of Clinical Oncology (36)
  6. Nature Publishing Group (28)

More Publishers

Results (563)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of <= 12 months
    Journal Article

    Lunning, M. A.; Migliacci, J. C.; Hilden, P.; Devlin, S. M.; Castro-Malaspina, H.; Giralt, S.; Perales, M. A.; Zelenetz, A. D.; Moskowitz, C. H.; Sauter, C. S.
    British Journal of Haematology (2016)

    Fulltext@MSK | Save
  • Central nervous system involvement in T-cell lymphoma: A single center experience
    Journal Article

    Gurion, R.; Mehta, N.; Migliacci, J. C.; Zelenetz, A.; Moskowitz, A.; Lunning, M.; Moskowitz, C.; Hamlin, P.; Horwitz, S.
    Acta Oncologica (2016)

    Fulltext@MSK | Save
  • Cancer-treatment-induced neurotoxicity - Focus on newer treatments
    Journal Article

    Stone, J. B.; DeAngelis, L. M.
    Nature Reviews Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center
    Journal Article

    Chihara, D.; Cheah, C. Y.; Westin, J. R.; Fayad, L. E.; Rodriguez, M. A.; Hagemeister, F. B.; Pro, B.; McLaughlin, P.; Younes, A.; Samaniego, F.; more...
    British Journal of Haematology (2016)

    Fulltext@MSK | Save
  • Novel immunotherapies in lymphoid malignancies
    Journal Article

    Batlevi, C. L.; Matsuki, E.; Brentjens, R. J.; Younes, A.
    Nature Reviews Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study
    Journal Article

    Van Den Neste, E.; Schmitz, N.; Mounier, N.; Gill, D.; Linch, D.; Trneny, M.; Milpied, N.; Radford, J.; Ketterer, N.; Shpilberg, O.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Advances in therapies for non-Hodgkin lymphoma in children
    Journal Article

    Kobos, R.; Terry, W.
    Hematology-American Society of Hematology Education Program (2015)

    Fulltext@MSK | Save
  • West Nile virus central nervous system infection in patients treated with rituximab: Implications for diagnosis and prognosis, with a review of literature
    Journal Article

    Morjaria, S.; Arguello, E.; Taur, Y.; Sepkowitz, K.; Hatzoglou, V.; Nemade, A.; Rosenblum, M.; Cavalcanti, M. S.; Lia Palomba, M.; Kaltsas, A.
    Open Forum Infectious Diseases (2015)

    Fulltext@MSK | Save
  • Screening and prevention of hepatitis B virus reactivation during chemotherapy
    Journal Article

    Ludwig, E.; Cohen, N.; Papanicolaou, G. A.; Seo, S. K.
    Oncology (Norwalk) (2015)

    Fulltext@MSK | Save
  • A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia
    Journal Article

    O'Brien, S. M.; Lamanna, N.; Kipps, T. J.; Flinn, I.; Zelenetz, A. D.; Burger, J. A.; Keating, M.; Mitra, S.; Holes, L.; Yu, A. S.; more...
    Blood (2015)

    Fulltext@MSK | Save